Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |

An ecosystem with the fastest and safest way to buy bitcoin

Our next company, Bitcoin Well Inc. (TSXV:BTCW) , is in the business of non-custodial FinTech through making bitcoin useful to everyday people, with the mission of enabling independence and enhancing safety. We spoke with CEO Adam O’Brie...
Brieanna McCutcheon | March 11, 2024 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

Buzz on the Bullboards: The Next Pot of Gold in 2022?

(Photo of mineralization from NFGC-21-195 approximately 285m down hole depth and Right: NFGC-21-202 approximately 146m down hole depth. Image via New Found Gold Corp.) We have waited three long years for this: St. Patrick’s Day is back, and so are al...
Stockhouse Editorial | March 15, 2022 |

A New and Exciting, Near-Surface, High-Grade Uranium Discovery in the Athabasca Basin

What do you get when you combine some of the best uranium geologists in the world, a world-class project in a mining-friendly jurisdiction, and a green energy fuel that is the most reliable and a cost-efficient baseload power source for the world? You get Baselode Energy C...
Dave Jackson | January 25, 2022 |

NIO, Rock Tech Lithium, Volkswagen: Forget hydrogen!

The pandemic shows it: humans are social creatures who long for their loved ones and want to experience something in good company. Mobility is the key to this. In the face of climate change and air pollution, electric cars are an obvious solution. But if you look at the stock ...
Nico Popp | February 18, 2021 |

CureVac, BioNTech, Valeo Pharma: Where is there still potential?

The race for vaccines against Covid-19 is fierce. Every day there are new water level reports - from setbacks to breakthroughs, everything is there. The Tübingen-based Company CureVac ( NASDAQ: CVAC ) recently started its phase study IIa in Peru and Panama. Around 700 people...
Nico Popp | October 16, 2020 |

BHP Group, Newcrest Mining, SolGold: Getting bogged down or putting all your eggs in one basket

When it comes to investing in commodity companies, the BHP Group ( NYSE: BHP ) is a household name. The British company is active worldwide, mining coal, iron ore, copper and other commodities and has long been considered a solid dividend earner. But recently the company has...
Nico Popp | September 18, 2020 |

Explorer's Shares Expected to 'Materially Rerate' in H2/20

Recent drill results from Troilus Gold's Quebec project are analyzed in a Red Cloud Securities report. In a May 15 research note, Red Cloud Securities analyst Jacob Willoughby reported that drilling continues to grow the Southwest zone at Troilus Gold Corp.'s (TLG...
Streetwise Reports | July 3, 2020 |

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |
1 2 3 4 5 6 7 8 9 10 ...